An Open Label Study of V81444 Using Positron Emission Tomography to Assess Occupancy of Brain Adenosine A2A Receptors & Functional & Perfusion MRI to Explore Effects on Regional Brain Activity & Perfusion in Healthy Male Volunteers.

Trial Profile

An Open Label Study of V81444 Using Positron Emission Tomography to Assess Occupancy of Brain Adenosine A2A Receptors & Functional & Perfusion MRI to Explore Effects on Regional Brain Activity & Perfusion in Healthy Male Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 10 May 2016

At a glance

  • Drugs CPI 444 (Primary)
  • Indications Parkinson's disease
  • Focus Pharmacodynamics
  • Sponsors Vernalis
  • Most Recent Events

    • 12 Dec 2012 Positive results were reported in a Vernalis media release.
    • 12 Dec 2012 Status changed from recruiting to completed, as reported by Vernalis.
    • 22 Aug 2012 Results are expected by the end of 2012 according to a Vernalis media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top